New epigenetic markers for prostate cancer discovered
New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been discovered.
Success in synthesizing biodegradable plastic materials using sunlight and CO2
Scientists have achieved an 80% conversion yield of a biodegradable plastic material from acetone and CO2, tackling the plastic waste crisis while moving toward carbon neutrality. Scientists have successfully synthesized 3-hydroxybutyrate, a raw materi…
Jurassic ichthyosaurs divided food resources to co-exist, researchers find
Early Jurassic ichthyosaur juveniles show predatory specializations, scientists have revealed.
3 Reasons You Might Want to Buy Intel Stock Despite Its Challenges
Intel is a troubled stock on many levels, but investors may have overreacted to its challenges.
2 Top Warren Buffett Stocks to Buy Right Now
These Berkshire Hathaway holdings are growth stocks, and they look like better bargains on the heels of big sell-offs.
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
Novartis recently announced encouraging results from its clinical trial of its Prolia biosimilar.
Credit Suisse Has the Market on Edge. What Should You Do?
The investment bank could be facing trouble, and shares are at an all-time low.
Is Eli Lilly Stock a Buy Following This Competitor’s Major Win?
Eli Lilly’s recent jump could be short-lived.
Can Stitch Fix Stock Recover in 2022?
The odds are stacked against this apparel retailer.
Stock Market Sell-Off: Is Unilever a Buy?
The British consumer staples giant deserves a lot more attention.
This FAANG Stock Is Down 35%; Buying It Could Be a Genius Move
Understanding the why behind a company’s struggles can make you a lot of money.
Can October Scare Up Ticket Sales for AMC Stock?
Business should pick up after a horrendous two months at the multiplex, but it won’t happen right away.
Researchers identify key player in cellular response to stress
An enzyme called Fic, whose biochemical role was discovered more than a dozen years ago, appears to play a crucial part in guiding the cellular response to stress, a new study suggests. The findings could eventually lead to new treatments for a variety…
Researchers discover new molecular driver of retinoblastoma
Despite decades of medical advances, children who develop the pediatric eye cancer retinoblastoma often lose their vision or an eye due to a lack of specific, targeted therapies and a poor molecular understanding of the cancer. Now researchers have dis…
Rainy days on track to double in the Arctic by 2100
Today, more snow than rain falls in the Arctic, but this is expected to reverse by the end of the century. A new study shows the frequency of rainy days in the Arctic could roughly double by 2100.
3 Ultra-High-Yielding Dividend Stocks to Buy With $1,000
These high-paying real estate stocks offer some security right now for new investors trading in a tough economy.
Why Warren Buffett Loves Coca-Cola Stock
The beverage king is a natural fit for the Buffett way of investing.
A Smart Way to Pass On Generational Wealth With a Roth IRA
Now is a great time to start thinking about ways to share your wealth with the next generation.
Where to Invest $10,000 in a Bear Market
Troubled times call for targeted investments, and these three stalwarts can still make you rich.
3 Incredibly Cheap Dividend Stocks
Here are three incredibly cheap-looking dividend stocks worth your attention in a down market.